Goldman Sachs Group Inc Spectrum Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024
SELL
$0.65 - $1.31 $208 - $419
-320 Reduced 1.65%
19,106 $18,000
Q2 2023

Aug 14, 2023
SELL
$0.65 - $1.31 $208 - $419
-320 Reduced 1.65%
19,106 $18,000
Q1 2023

May 14, 2024
BUY
$0.38 - $1.07 $2,468 - $6,949
6,495 Added 50.23%
19,426 $14,000
Q1 2023

May 11, 2023
BUY
$0.38 - $1.07 $2,468 - $6,949
6,495 Added 50.23%
19,426 $14,000
Q4 2022

May 14, 2024
SELL
$0.32 - $0.52 $23,006 - $37,384
-71,894 Reduced 84.76%
12,931 $4,000
Q4 2022

Feb 13, 2023
SELL
$0.32 - $0.52 $23,006 - $37,384
-71,894 Reduced 84.76%
12,931 $4,000
Q3 2022

May 14, 2024
SELL
$0.43 - $1.56 $82,275 - $298,487
-191,338 Reduced 69.28%
84,825 $37,000
Q3 2022

Nov 10, 2022
SELL
$0.43 - $1.56 $82,275 - $298,487
-191,338 Reduced 69.28%
84,825 $0
Q2 2022

May 14, 2024
BUY
$0.7 - $1.4 $193,314 - $386,628
276,163 New
276,163 $215,000
Q2 2022

Aug 15, 2022
BUY
$0.7 - $1.4 $19,664 - $39,328
28,092 Added 11.32%
276,163 $215,000
Q1 2022

May 16, 2022
SELL
$0.63 - $1.59 $1.68 Million - $4.24 Million
-2,668,648 Reduced 91.49%
248,071 $320,000
Q4 2021

Feb 14, 2022
BUY
$1.27 - $2.42 $3.2 Million - $6.09 Million
2,518,287 Added 632.05%
2,916,719 $3.71 Million
Q3 2021

Nov 10, 2021
BUY
$2.15 - $3.82 $856,628 - $1.52 Million
398,432 New
398,432 $868,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email